RSS Feeds
Search

Press releases

Press releases

Displaying 1..1 of 1 - per page
Order by
Recombinant erythropoietin available: sufficient for the requirements of companies involved in new drug development or drug delivery system proof-of-concept testing
Dragon Pharmaceuticals offers surplus stocks of recombinant EPO (erythropoietin) More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Erythropoiesis-Stimulating Agents in the Treatment of Chemotherapy Induced Anemia and Anemia in Chronic Kidney Disease in the US
Aug 2011 - 6 pages - $500
Anemia - Pipeline Review, Q1 2011
Feb 2011 - 129 pages - $500
Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Aug 2008 - 120 pages - $1,040
Anemia Therapy Area Pipeline Report
Nov 2010 - 738 pages - $1,495
Vitamin Deficiency Anemia - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, Q2 2011
May 2011 - 38 pages - $500
Iron Deficiency Anemia - Pipeline Review, Q4 2010
Dec 2010 - 36 pages - $500
CV & Diabetes Market Forecast
Jan 2009 - $15,200
Anemia - Pipeline Assessment and Market Forecasts to 2017
Nov 2010 - 55 pages - $2,000
Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Aug 2011 - 113 pages - $3,500
More Related Market Research Reports >>>

Your selection

Industry sector
Service del
Materials del
Therapeutic target
Cardiovascular del
Anemia del

Browse By

Therapeutic target
Anemia (other)
Anemia, erythropoetin tx
Anemia, sickle cell
Hemolytic anemia
Year
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us